deep-brain-stimulation
(3)
Gregory Fischer
Gregory Fischer is the co-founder and CEO of AiM Medical Robotics, a Worcester, Massachusetts company building a portable, MRI-compatible surgical robot for neurosurgery. A robotics engineer with a PhD from Johns Hopkins, Fischer spent nearly two decades as a professor at Worcester Polytechnic Institute, where he directed the Automation and Interventional Medicine (AIM) Robotics Lab and founded the PracticePoint medtech R&D center. He turned his NIH-funded research into a company aiming to bring real-time image guidance and submillimeter robotic precision into the operating room, with a first-in-human clinical study on the horizon after a $8.1 million Series A in 2025.
Scott Kokones
Scott Kokones is co-founder and CEO of Enspire DBS Therapy, a Cleveland Clinic portfolio company building an implantable deep brain stimulation system paired with physical rehab to restore arm function in stroke survivors. He is running the RESTORE pivotal trial after the EDEN proof-of-concept study, having raised $27.9M total including a $17.6M Series B in 2023 and a $10.3M Series B1 in January 2026. Alongside Enspire he is a general partner at Guide Medical Ventures and a co-founder of Qr8 Health and CardioSolv Ablation Technologies. His earlier career runs through Intelect Medical, Boston Scientific, Enpath Medical, and Medtronic.
MJ Antonini
MJ Antonini is the co-founder and CEO of NeuroBionics, an MIT spinout building hair-thin, flexible bioelectronic fibers that thread through blood vessels to reach deep neural structures - delivering deep brain stimulation without opening the skull. A Harvard-MIT Health Sciences and Technology graduate who trained in both medicine and engineering, he turned a decade of fiber research from Polina Anikeeva's MIT lab into a venture-backed company that raised an oversubscribed $10M seed round to push toward first-in-human trials.